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Adult xanthogranulomatosis is an uncommon disorder in 
which dermal macrophages accumulate cholesterol intracel-
lularly despite normal plasma cholesterol levels . In an at-
tempt to elucidate an underlying biochemical abnormality in 
this disorder, we studied the rates of 1251-labeled low-density 
lipoprotein degradation, and intracellular cholesterol syn-
thesis, in human monocyte-derived macrophages of three 
patients with adult xanthogranulomatosis. In all three pa-
tients, the rates of cellular 1251 - low-density lipoprotein deg-
radation and of cholesterol synthesis were 22 - 37% and 14-
84% higher than those of the respective normal controls 
A dult xanthogranulomatosis (XG) is an uncommon disorder in which dermal macrophages accumulate lipids intracellular/y, despite normal levels of plasma . lipids [1- 6]. Although a single XG lesion may be the result of a local reactive process, the appearance of 
multiple lesions in an individual is probably the result of a more 
generalized disorder. The accumulated lipids in adult XG lesions 
were shown in two cases to be comp.osed of mainly cholesteryl esters 
[5] and cholesteryl esters and triglycerides [6]. Plasma lipoproteins 
were also shown to be normal in these two cases [5,6]. In one of 
these cases, we measured, in addition, plasma apolipoprotein (apo) 
levels and found increased levels of very-low-density lipoprotein 
(VLDL) apo E, especially apo E-III [6]. Apo E-lII is not a component 
of low-density lipoprotein (LDL), and macrophages do not use it as 
a ligand for receptor-mediated catabolism of LDL [7,8]. Normal 
VLDL does not bind to the LDL receptor on macrophages, but the 
addition of apo E to normal VLDL results in its increased uptake by 
the macrophage LDL receptor [8]. On the other hand, cholesterol-
loaded macrophages have been shown to secrete large amounts of 
apo E along with the excretion of excess cholesterol [9] . This is most 
likely to target the secreted cholesterol to the liver, thereby facili-
tating "reverse cholesterol transport" [9]. One possible mechanism 
Manuscript received December 4, 1992; accepted for publication June 22, 
1993. 
Reprint requests to: Dr. Reuven Bergman, Department of Dermatology, 
Rambam Medical Center, POB 9602, 31096 Haifa, Israel. 
Abbreviations: apo, apolipoprotein; HMDM, human monocyte-derived 
macrophages; MDM, monocyte-derived macrophages; VLDL, very-low-
density lipoprotein; XG, xanthogranulomatosis. 
(p < 0.01). These findings suggest that in MDM of adult 
xanthogranulomatosis patients, the uptake and degradation 
of low-density lipoprotein - derived cholesterol and intracel-
lular cholesterol biosynthesis are enhanced. Because dermal 
macrophages are derived from blood monocytes, it is possible 
that such an enhancement might playa role in the accumula-
tion of cholesteryl esters in the macrophages that form the 
xanthogranulomatosis lesions. Key words: xanthogranulo-
matosis/low-density lipoprotein degradation/cholesterol 
synthesis.] ltlVest Dermatol101:880-882, 1993 
by which macrophages might accumulate cholesterol in adult XG is 
by enhanced LDL cholesterol uptake and/or increased intracellular 
cholesterol synthesis. Therefore, we have investigated the rates of 
LDL degradation and intracellular cholesterol synthesis in mono-
cyte-derived macrophages of three adult patients with XG. 
MATERIALS AND METHODS 
Subjects Two men and one woman, aged 36, 43, and 56 years, respec-
tively, each with more than 20 XG lesions, of which at least one had been 
confirmed histologically [2], were studied. Their medical histories were 
unremarkable except for the woman (patient 3), who had a euthyroid goiter. 
None of the patients was taking any medication, and all of them were on a 
normal diet at the time of study. Fasting plasma triglyceride and cholesterol 
levels were normal in all three patients. 
Controls Each patient was studied 011 a different day. A normal control 
was included on the same day of study of each patient. The results were also 
compared to the results obtained in a separate group of 12 normal controls 
whom we had studied under similar experimental conditions. 
Preparation of Cells Human monocyte-derived macrophages (HMDM) 
were prepared from the blood of the fasting subjects by density-gradient 
centrifugation using the method of Boyum [10]. Twenty milliliters of blood 
anticoagulated with sodium heparin (final concentration 10 Ujml) were 
layered over 15 ml Ficoll-Paque. After centrifugation at 500 X g for 30 min 
at 23°C, the mixed mononuclear cell band was removed by aspiration and 
the cells washed twice at 4°C in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with L-glutamine (final concentration 2 mM), 100 
Ujml penicillin, and 100 ,ugjml streptomycin. The cells were plated at 
3 X 105 monocytes per 16-mm dish (Primaria Brand, Falcon Labware) in the 
same medium (0.5 ml) containing 20% autologous serum. After 2 h incuba-
tion at 37 °C in 5% CO2 -95% air, nonadherent cells were removed by three 
washes with serum-free medium. The cells were placed in fresh medium 
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Table I. 
..--
--patient 
control 
LDL Cellular Degradation by HMDMs from XG 
Patients and Controls' 
989 ± 24b 
809 ± 36 
2 
1134 ± 34b 
836 ± 32 
3 
1199 ± 47b 
874 ± 35 
--: Results are expressed as ng I2SI-LDL protein/mg cell protein/5 h and represent the 
fl1ean ± standard deviation of nine plates for each study. 
6 p < 0.01. 
containing 20% autologous serum, fed twice weekly, and used for ex peri-
J1lents after 7 d In culture. 
J..DL Uptake and Degradation by Maerophages LDL, which was ob-
·ned from plasma of healthy volunteers, was iodinated by the method of 
McFarlane as modified for lipoproteins [11]. The uptake and degradation of 
125I-Iabeled LDL by cells was measured as previously described (12). Cells 
ere -washed with phosphate-buffered saline, and 0.5 ml of serum-free 
;ediuITl containing 25 J1.g protein/ml of I 25I-labeled LDL (150-300 cpm/ 
g) -was added to 16-mm dishes of cells. After 5 h incubatIOn, the medIa were 
Pemoved from the cells, and trichloroacetic-acid-soluble, free-iodide r~dio­
! ctivity -was determined. Degradation rates were corrected for cell-free InCU-~ations that were carried out in parallel. Results were expressed as Jig of 
125I_LDL degraded/mg cell protein. Protein was measured by the method of 
J..owry et al [13] . 
~easurement of Cellular Cholesterol Synthesis HMDMs were incu-
bated for 18 h in DMEM containing autologous serum. Cells were then 
washed and further incubated in serum-free medium for 2 h with 1,2_14C_ 
odiuIn acetate (1.25 mM, 10 J1.Ci/ml), as previously described (14) . At the ~nd of the incubation, the incorporation of radioactivity into ceHular nones-
terified cholesterol and into the sterol moiety of cellular cholesteryl ester ~as 
determined by thin-layer chromatography, after cell lipId extractlon WIth 
hexane/isopropanol (3: 1, v/v) [14]. 
Statistical Analysis Each separate experiment was performed in tripli-
cate. Student t test was used to analyze the significance of the data. The 
results are the means ± SD. 
RESULTS 
In each of the three patients, the rates of 125I_LOL degradation bX 
MDMs were significantly higher, by 22-37%, than in each of their 
respective normal controls (p < 0.01) (Table I). Similarly, intracel-
lular cholesterol biosynthesis was significantly increased 111 all three 
patients, by 14-84%, in comparison to each of the respectiv~ c~n­
trol subjects (p < 0.01) (Table II). These values were also slgmfi-
candy higher (p < 0.01) than the average rates of cellular 125J_LDL 
uptake and degradation (704 ± 39 ng 125I-LDL protein/mg cell 
protein/5 h) and intracellular cholesterol synthesis (1067 ± 43 
cpm/rng cell protein), respectively, measured in a sep.a~ate group of 
12 normal subjects under similar experimental conditions. 
DISCUSSION 
Although hypercholesterolemia is an important risk factor., it does 
not explain all cases of xanthomatosis and/or atherosclerotic Ische-
mic diseases [15]. In humans, normolipidemic xanthomatosis, in-
cluding adult XG, exists, and ischemic diseases secondary to athero-
sclerosis occur in many patients who have no past or present 
hypercholesterolemia [6 ,15 ,16]. There seems to be some similarity 
between the atherosclerotic process and most types of xanthomas, 
because both are characterized by the accumulation of cholesterol-
loaded macrophages [17-20] . The major pathway for delivery of 
exogenous cholesterol to most cells is the uptake ofLOL [21]. LOL 
receptor activity in these cells is tightly coupled to the leve! of 
cellular cholesterol, thus preventing it~ intracellular accumulatIOn. 
MDMs, however, also have scavenger or acetyl-LOL receptors, 
which are not regulated by intracellular cholesterol levels [8,22,~3]. 
It has been demonstrated in vitro that LDL modified by acetylation 
could induce the transformation of macrophages into foam cells via 
the uptake by these scavenger receptors [24]. 
In the present study, the degradation rates of unmodified LOL 
were significantly increased in the MOMs of all three of our pa-
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Table II. 
Patient 
Control 
Cellular Cholesterol Synthesis in HMDMs from XG 
Patients and Controls· 
2008 ± 114b 
1106 ± 89 
2 
1219 ± 49b 
1069 ± 61 
3 
1409 ± 31 b 
917 ± 23 
• Results are expressed as cpm/mg cell protein and represent the mean ± standard 
deviation of nine plates for each stndy. 
! p < 0.01. 
tients. 1251_LDL degradation rate is considered to reflect 1251_LDL 
uptake because the degradation of LOL occurs intracellularly 
[22,25]. To rule out endocytosis-independent degradation in the 
medium via release of cellular proteinases, we studied J774Al mac-
rophage degradation of 125I_LDL with the addition of macrophage-
conditioned medium that had been pre incubated in the absence or 
presence of unlabeled LDL. Preincubation with LDL did not in-
crease the 1251_LOL degradation rate by the macrophages (data not 
shown) . Furthermore, incubation of the cells with chloroquine, a 
lysosomal inhibitor, blocked 125I_LOL degradation completely 
(data not shown). This implies that lysosomal hydrolysis is essential 
for 12sI_LDL degradation and that only intracellular degradation is 
involved. The increased degradation rates of 125I-LOL by the 
MOMs of our patients were therefore most likely the result of an 
increased uptake of LDL by these cells. 
In addition, the rates of intracellular cholesterol synthesis were 
not decreased, as expected from the enhanced LD L degradation. On 
the contrary, they were significantly increased in the MOMs of all 
three patients. This is of interest because hI vitro lipogenesis studies, 
using sodium [14CJacetate on xanthoma tissue from both hyperlipi-
demic and normolipidemic patients with different types of xantho-
mas, showed increased synthesis of all major lipid groups [26]. 
These data exemplified considerable itl situ lipid synthesis in xanth-
oma tissue and suggested that local lipogenesis contributes to the 
intracellular accumulation of lipids [26]. 
Our findings might suggest that in MOMs of adult XG patients, 
uptake of LDL-derived cholesterol and intracellular cholesterol 
biosynthesis are both enhanced. Because dermal macrophages are 
derived from blood monocytes [27], it is possible that such an en-
hancement might play a role in the process of accumulation of 
cholesteryl esters in the macrophages that form the XG lesions. As 
the number of the cases in our study was small, more cases with this 
uncommon disorder should be studied. 
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